These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31724666)

  • 1. Engineering microglia as intraoperative optical imaging agent vehicles potentially for fluorescence-guided surgery in gliomas.
    Guo L; Zhang X; Wei R; Li G; Sun B; Zhang H; Liu D; Wang C; Feng M
    Biomater Sci; 2020 Feb; 8(4):1117-1126. PubMed ID: 31724666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents.
    Habimana-Griffin L; Ye D; Carpenter J; Prior J; Sudlow G; Marsala L; Mixdorf M; Rubin J; Chen H; Achilefu S
    J Biomed Opt; 2020 Feb; 25(2):1-13. PubMed ID: 32112540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas.
    Patil CG; Walker DG; Miller DM; Butte P; Morrison B; Kittle DS; Hansen SJ; Nufer KL; Byrnes-Blake KA; Yamada M; Lin LL; Pham K; Perry J; Parrish-Novak J; Ishak L; Prow T; Black K; Mamelak AN
    Neurosurgery; 2019 Oct; 85(4):E641-E649. PubMed ID: 31069381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection.
    Li L; Du Y; Chen X; Tian J
    Mol Imaging Biol; 2018 Dec; 20(6):930-939. PubMed ID: 29651576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
    Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
    J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
    Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
    Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraoperative Near-Infrared Optical Imaging Can Localize Gadolinium-Enhancing Gliomas During Surgery.
    Lee JY; Thawani JP; Pierce J; Zeh R; Martinez-Lage M; Chanin M; Venegas O; Nims S; Learned K; Keating J; Singhal S
    Neurosurgery; 2016 Dec; 79(6):856-871. PubMed ID: 27741220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
    Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
    J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
    Haider SA; Lim S; Kalkanis SN; Lee IY
    J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models.
    Ni XR; Zhao YY; Cai HP; Yu ZH; Wang J; Chen FR; Yu YJ; Feng GK; Chen ZP
    J Neurooncol; 2020 Jun; 148(2):245-258. PubMed ID: 32405996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence Imaging/Agents in Tumor Resection.
    Stummer W; Suero Molina E
    Neurosurg Clin N Am; 2017 Oct; 28(4):569-583. PubMed ID: 28917285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.
    Folaron M; Strawbridge R; Samkoe KS; Serafini CE; Roberts DW; Davis SC
    J Neurosurg; 2019 Sep; 131(3):724-734. PubMed ID: 30192200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance and photoacoustic imaging of brain tumor mediated by mesenchymal stem cell labeled with multifunctional nanoparticle introduced via carotid artery injection.
    Qiao Y; Gumin J; MacLellan CJ; Gao F; Bouchard R; Lang FF; Stafford RJ; Melancon MP
    Nanotechnology; 2018 Apr; 29(16):165101. PubMed ID: 29438105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional upconversion nanoparticles for targeted dual-modal imaging in rat glioma xenograft.
    Yang L; Shao B; Zhang X; Cheng Q; Lin T; Liu E
    J Biomater Appl; 2016 Sep; 31(3):400-10. PubMed ID: 27388895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of Brain Tumors with Infrared-Labeled Aptamers for Fluorescence-Guided Surgery.
    Zamay G; Koshmanova A; Narodov A; Gorbushin A; Voronkovskii I; Grek D; Luzan N; Kolovskaya O; Shchugoreva I; Artyushenko P; Glazyrin Y; Fedotovskaya V; Kuziakova O; Veprintsev D; Belugin K; Lukyanenko K; Nikolaeva E; Kirichenko A; Lapin I; Khorzhevskii V; Semichev E; Mohov A; Kirichenko D; Tokarev N; Chanchikova N; Krat A; Zukov R; Bakhtina V; Shnyakin P; Shesternya P; Tomilin F; Kosinova A; Svetlichnyi V; Zamay T; Kumeiko V; Mezko V; Berezovski MV; Kichkailo A
    J Am Chem Soc; 2024 Sep; 146(36):24989-25004. PubMed ID: 39186481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
    Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
    J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
    Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
    Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Factors Affecting 5-ALA Fluorescence Intensity in Visualizing Glial Tumor Cells-Literature Review.
    Mazurek M; Szczepanek D; Orzyłowska A; Rola R
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
    Chohan MO; Berger MS
    J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.